Effect of antispasmodic agents, alone or in combination, in the treatment of Irritable Bowel Syndrome: Systematic review and meta-analysis
Authors:
- G. Vázquez-ElizondoGVG. Vázquez-Elizondo
- J.A. González-GonzálezJGJ.A. González-González
- R. Gutiérrez-UdaveRGR. Gutiérrez-Udave
- H.J. Maldonado-GarzaHMH.J. Maldonado-Garza
- F.J. Bosques-PadillaFBF.J. Bosques-Padilla
Open Access
- 1 April 2012
- journal article
- review article
- Published by Elsevier in Revista de Gastroenterología de México
- Vol. 77 (2) , 82-90
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Randomised clinical trial: otilonium bromide improves frequency of abdominal pain, severity of distention and time to relapse in patients with irritable bowel syndromeAlimentary Pharmacology & Therapeutics, 2011
- Clinical trial: the efficacy of alverine citrate/simeticone combination on abdominal pain/discomfort in irritable bowel syndrome ‐ a randomized, double‐blind, placebo‐controlled studyAlimentary Pharmacology & Therapeutics, 2010
- Effect of fibre, antispasmodics, and peppermint oil in the treatment of irritable bowel syndrome: systematic review and meta-analysisBMJ, 2008
- Systematic review: the efficacy of treatments for irritable bowel syndrome – a European perspectiveAlimentary Pharmacology & Therapeutics, 2006
- Applied Principles of Neurogastroenterology: Physiology/Motility SensationGastroenterology, 2006
- Determinanten der Plazebowirkung beim Reizdarm-SyndromDMW - Deutsche Medizinische Wochenschrift, 2005
- Measuring inconsistency in meta-analysesBMJ, 2003
- Otilonium bromide in irritable bowel syndrome: a double‐blind, placebo‐controlled, 15‐week studyAlimentary Pharmacology & Therapeutics, 1998
- Meta-Analyses of Randomized Controlled TrialsNew England Journal of Medicine, 1987
- Primary, Secondary, and Meta-Analysis of ResearchEducational Researcher, 1976